Langland appoints Angela Rochelle to clinical trial diversity role

Langland has announced the appointment of Angela Rochelle as account director, head of diversity initiatives in clinical trials.

Rochelle will be the agency’s leading advocate for diversifying patient representation in Clinical Trial Experience (CTE).

She will collaborate with Langland’s established clinical trial inclusivity taskforce—a team committed to designing and deploying clinical trial communications that proactively address common barriers experienced by underrepresented communities, and advising on best practices throughout the agency’s US, UK, and Australia offices.

Rochelle’s appointment comes as the agency reaffirms its commitment to equity and fair representation in clinical trials, and in the broader healthcare communications industry.

Prior to joining Langland, Rochelle spent time at some of the country’s leading multicultural advertising agencies working with high-profile clients such as Unilever, General Motors, Walmart, and Proctor & Gamble.

Her more than two decades of industry experience has also involved successful roles in healthcare advertising account management, including recent clinical research and patient advocacy work with clients including Bristol Myers Squibb.

Rochelle now brings her considerable expertise to Langland’s established legacy of excellence in clinical trial recruitment and experience.

Recognising that equitable representation should be a goal across the industry, Langland has also increased its focus on practices that build a more diverse and inclusive workplace.

Across all of its locations, these practices include anonymised resumé submissions, mandatory unconscious bias training, career programs, and school relationships for people from mixed socio-economic backgrounds, as well as internal support communities for women, LGBTQ+ (Lesbian, Gay, Bisexual, Transgender, Queer/Questioning, and Related Communities), and BIPOC (Black, Indigenous and People of Color) employees and their allies.

In Langland’s US office, as more staff have been brought on to support expanding CTE business, 80% of new hires self-identify as BIPOC; overall, 40% of total US staff—including 40% of agency leadership at the account director level and above—self-identify as BIPOC.

Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.